EDITORIAL
Accepted on 17 Jun 2025
"Editorial: Community Series in Targeting Signaling Pathways in Inflammatory Diseases -Volume II"
doi 10.3389/fimmu.2025.1639004
- Frontiers in Immunology
- Inflammation
- Research Topics
- Community Series in Targeting Signalling Pathways in Inflammatory Diseases - Volume II
Community Series in Targeting Signalling Pathways in Inflammatory Diseases - Volume II
14k
Total downloads
42k
Total views and downloads
Articles
ORIGINAL RESEARCH
Published on 08 May 2025
Airway epithelial cell-specific deletion of EGFR modulates mucoinflammatory features of cystic fibrosis-like lung disease in mice
doi 10.3389/fimmu.2025.1493950
- 929 views
REVIEW
Published on 26 Feb 2025
Regulation of the immune microenvironment by SUMO in diabetes mellitus
doi 10.3389/fimmu.2025.1506500
- 1,511 views
REVIEW
Published on 07 Feb 2025
Targeting Nrf2/KEAP1 signaling pathway using bioactive compounds to combat mastitis
doi 10.3389/fimmu.2025.1425901
- 1,587 views
ORIGINAL RESEARCH
Published on 15 Jan 2025
Integrative RNA, miRNA, and 16S rRNA sequencing reveals immune-related regulation network for glycinin-induced enteritis in hybrid yellow catfish, Pelteobagrus fulvidraco ♀ × Pelteobagrus vachelli ♂
doi 10.3389/fimmu.2024.1475195
- 922 views
REVIEW
Published on 31 Oct 2024
Understanding the molecular regulatory mechanisms of autophagy in lung disease pathogenesis
doi 10.3389/fimmu.2024.1460023
- 1,711 views
- 2 citations
REVIEW
Published on 05 Sep 2024
The production, function, and clinical applications of IL-33 in type 2 inflammation-related respiratory diseases
doi 10.3389/fimmu.2024.1436437
- 3,534 views
- 5 citations
REVIEW
Published on 04 Jun 2024
Role of long non-coding RNA in inflammatory bowel disease
doi 10.3389/fimmu.2024.1406538
- 2,730 views
- 4 citations
ORIGINAL RESEARCH
Published on 13 May 2024
Corilagin alleviates atherosclerosis by inhibiting NLRP3 inflammasome activation via the Olfr2 signaling pathway in vitro and in vivo
doi 10.3389/fimmu.2024.1364161
- 2,408 views
- 3 citations
REVIEW
Published on 10 May 2024
Beyond oncology: Selinexor’s journey into anti-inflammatory treatment and long-term management
doi 10.3389/fimmu.2024.1398927
- 2,432 views
- 3 citations
REVIEW
Published on 02 May 2024
The aging lung: microenvironment, mechanisms, and diseases
doi 10.3389/fimmu.2024.1383503
- 6,256 views
- 9 citations
ORIGINAL RESEARCH
Published on 22 Apr 2024
hCeO2@ Cu5.4O nanoparticle alleviates inflammatory responses by regulating the CTSB–NLRP3 signaling pathway
doi 10.3389/fimmu.2024.1344098
- 1,676 views
- 4 citations
